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Abstract The treatment of acanthamoebiasis is a great prob-
lem.Most cerebral invasions end with death, and the treatment
of ocular invasions is usually long-lasting and not very effec-
tive. Numerous plant extracts and substances isolated from
plants, which are effective against trophozoites or cysts, have
been studied in the treatment of acanthamoebiasis. However,
no agents that are simultaneously effective against both devel-
oping forms of amoebae have been discovered yet. It seems
that such a plant which fulfils both tasks is Artemisia annua L.
Our studies showed that water, alcohol and chloroform ex-
tracts from the herb A. annua L. can be applied in general
and local treatment or in combined therapy with antibiotics
in the treatment of acanthamoebiasis. Extracts from this plant
show not only in vitro but also in vivo effects. Studies carried
out on experimental animals infected with amoebae show that
the application of these extracts significantly prolongs the sur-
vival of the animals.
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Introduction
Free-living amoebae belonging to the genus Acanthamoeba are
organisms commonly occurring in the environment surrounding
humans. They feed on bacteria, mushrooms and other protozoa
and are perfectly adjusted to the environment (Khan 2009).
These organisms have been found in samples of soil, air, and
fresh and salt water, as well as in air conditioning systems, in
water supplied by waterworks, showers, sanitary appliances,
swimming pools, dialysis machines and contact lens fluid. Tro-
phozoites and cysts of amoebae have also been discovered in
oceanic deposits, bottled mineral water and nasal and throat mu-
cosal smears (De Jonckheere 1991; Mergeryan 1991; Szenasi et
al. 1998; Visvesvara and Stehr-Green 1990). The first sugges-
tions that amoebae may cause diseases in humans come from
1958 from the USA (Culbertson et al. 1959; Fowler and Carter
1965). At present, human cases of granulomatous amoebic en-
cephalitis (GAE), aspiration pneumonia (AP) and skin inflam-
mations, and in particular, Acanthamoeba keratitis (AK) are not-
ed worldwide (Yoder et al. 2012; Marciano-Cabral et al. 2000;
Marciano-Cabral andCabral 2003;Wanachiwanawin et al. 2012;
Kao et al. 2012).
Chemotherapy in the case of Acanthamoeba sp. infection is
a great problem. Most cerebral infections end with the pa-
tient’s death, while the treatment of ocular acanthamoebiasis
is usually long-lasting and not very effective. Only a few cases
of effective chemotherapy in the very early stage of infection
and by using highly toxic drugs have been reported (Seal
2003; Kitagawa et al. 2003; Polat and Vural 2012). In the late
stage of infection, most medications are not effective
(Dougherty et al. 1994; Ficker et al. 1990; Horne et al. 1994;
Murdoch et al. 1998; Berra et al. 2013).
The broad applicability of chemotherapeutic agents in
Acanthamoeba sp. infection is not doubted, but most
drugs are highly toxic for humans, causing adverse re-
actions. Hence, alternative and natural medicinal sub-
stances which could prove suitable for use in cases of
amoeba infection are sought.
Due to its potential antiparasitic properties, we decid-
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We investigated the possibility to use them externally as
well as internally to treat infections caused by free-living
amoebae, in particular in the treatment of Acanthamoeba ker-
atitis (AK) and granulomatous amoebic encephalitis (GAE) or
Acanthamoeba pneumonitis (PA).
Material and methods
Dried aerial parts of A. annua L. from China were obtained
from the company Magiczny Ogród (Poland). One hundred
millilitre of hot distilled water was poured on the pulverized
plant material in the quantity of 2–3 g and a hot water infusion
(tea) was obtained (De Donno et al. 2012; Suberu et al. 2013).
The next portions of the dried material in the quantity of 5–
10 g were extracted with ethanol or chloroform (Sharma et al.
2014) in the Soxhlet apparatus (about 30 cycles). The obtained
methanol or chloroform extracts were filtered and then vapor-
ized to dryness under a vacuum. The dry remnant was dis-
solved in hot distilled water. Also, a ready-dried extract from
A. annua 10:1 made in China (Magiczny Ogród, Poland),
which was also dissolved in hot distilled water, and pure
artemisinin (from the company Sigma Chemical Company)
were used in the study.
The studies on the influence of the extracts on amoebae
were carried out on the strain 309 Acanthamoeba
castellanii—pathogenic for mice and isolated from the envi-
ronment (Kasprzak andMazur 1972)—and on the strain Ac32
Acanthamoeba sp—pathogenic for humans and isolated from
a case of Acanthamoeba keratitis, genotype T4 (accession
number KP184479). The amoebae were grown in axenic liq-
uid cultures containing 2 % Bacto Casiton (Difco) and 10 %
normal horse serum according to the procedure described by
Červa (1969) and on non-nutrient agar (NN) containing 2 %
non-nutrient agar Difco poured on the Petri dish and covered
with a suspension of the bacterium Enterobacter aerogenes.
The pathogenic properties of amoebae were tested by in-
fecting 2-week-old white mice of the BALB-c strain using the
procedure described by Kasprzak and Mazur (1972) and
Mazur (1984).
To the axenic culture of amoebae containing 5×104 cells/
ml, we added hot water infusion (tea), methanol or chloroform
extract in the quantity corresponding to 1–300 mg of dry mass
of the plant in 1 ml, ready dry extract 10:1 made in China in
the quantity from 1 to 20 mg/ml and pure artemisinin (Sigma)
in the quantity of 0.005 to 0.2 mg/ml. The increase in the
number of amoebae was studied 24, 48 and 72 h after adding
to the culture the extracts or pure substance in the log phase of
growth using a Thoma counting chamber. The control was the
amoeba culture without the plant extract. The half maximal
inhibitory concentration (IC50), i.e. the lowest concentration
of the studied substance inhibiting the increase of amoebae by
50 %, was determined.
The second method of investigating plant extracts was
based on the amoeba grown on NN agar, on which a filter
paper was saturated with the extract solution. Solutions with
the concentration of 5 and 50 mg of dry mass/ml were used.
The controls were filter papers saturated with sterile water.
The influence of the extract on the culture increase and migra-
tion of amoebae was observed for 7 days.
Study on the influence ofA. annua extracts on the course of
infection with amoebae was tested on the mice strain BALB/c
(Kasprzak and Mazur 1972; Mazur 1984). The infected mice
received extracts per os, from the first day after becoming
infected until the seventh day, in the volume of 0.5 ml con-
taining 200 mg of dry mass in 1 ml.
All of the experiments were repeated five to seven times.
Tests on the animals were repeated five times, using five to ten
animals for each test series.
Results
Table 1 presents the IC50 values for the studied extracts ob-
tained from A. annua. IC50 was determined at 24, 48 and 72 h
after infection with amoebae of the genus Acanthamoeba. It
was found in the in vitro study that all extracts effectively
inhibited the increase of amoebae and caused encystation in
cultures. There was no statistically significant difference be-
tween the two studied strains of Acanthamoeba sp.
The pure artemisinin preparation affected amoebae from
100 to 300 times more strongly than the studied extracts.
The most active anti-amoeba extract was chloroform extract.
The Chinese water extract 10:1 was approximately 50 %
weaker than the best chloroform extract.
Studies on the effect of extracts on amoebae grown on agar
plates showed that filter papers already saturated with the ex-
tract with the concentration of 5 mg/ml inhibited the growth
and migration of amoebae, and moreover caused the increase
in the volume of amoebae and their strong vacuolation
(Fig. 1). Vacuolated amoebae did not transform into cysts
and after several days became decayed. In Fig. 1, strongly
Table 1 Anti-amoebic activity of extracts from A. annua and pure
artemisinin
Compound IC50 at 24 h
[mg mL−1]
IC50 at 48 h
[mg mL−1]
IC50 at 72 h
[mg mL−1]
Artemisinin pure (Sigma) 0.09* 0.12* –
Methanol extract 15.0 12.5* 8.1*
Chloroform extract 17.4 14.1* 9.2*
Chinese water extract 10:1 26.4 21.2 15.2*
Hot water infusion (tea) 208 197 145
*P< 0.05 statistically significant difference in comparison with the con-
trol during the same time interval; n = 6
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vacuolated amoebae within the region of extract action can be
observed.
Tests concerning the therapeutic action of plant extracts on
the experimental infection with Acanthamoeba show that, fol-
lowing the application of the extracts, the animals survived
considerably longer (three to four times) and infection passed
into a chronic condition. Table 2 presents the survival time for
mice infected with Acanthamoeba sp. following the applica-
tion of the plant extracts.
Discussion
Clinical symptoms of granulomatous amoebic encephalitis in
humans are primarily strong headache, neurological disorders
such as hallucinations, disorientation and visual disturbances,
high fever and coma (Martinez and Visvesvara 1997). Kerati-
tis meanwhile is characterized by severe eye pain, sensitivity
to light and petechial hemorrhage (Kosik-Bogacka et al. 2010;
Wanachiwanawin et al. 2012; Hadaś and Derda 2013). In the
lungs, amoebae develop numerous inflammatory foci with a
serous exudate containing trophozoites and cysts (Vernon et
al. 2005). Skin lesions are characterized by numerous ulcers of
varying extent. All forms of infection are usually chronic
(Paltiel et al. 2004; Galarza et al. 2009). The chronic character
of amoebic invasions in human is caused by the ability of
trophozoites to transform into cysts. Cysts, in turn, are resis-
tant to most chemotherapeutic agents.
So far, in the therapy of acanthamoebiasis, the possibility to
use plant extracts and substances isolated from such plants as
Buddleia cordata (Rodríguez-Zaragoza et al., 1999),
Pterocaulon polystachyum (Rodio et al., 2008; Sauter et al.,
2011), Arachis hypogaea, Curcuma longa, Pancratinum
maritimum (El-Sayed et al., 2012), Eryngium planum,
Eryngium maritimum, Solidago virgaurea, Solidago
graminifolia,Pueraria lobata,Rubus chamaemorus,Tanacetum
vulgare (Derda et al., 2009, 2012, 2013), Peucedanum
caucasicum, Peucedanum palimbioides, Peucedanum
chryseum, Peucedanum longibracteolatum, Satureja cuneifolia,
Melissa officinalis (Malatyali et al., 2012a, b), Pouzolzia indica
(Roongruangchai et al., 2010), Salvia sclarea (Kuźma et al.,
2015), Teucrium polium, Teucrium chamaedrys (Tepe et al.,
2012), Croton pallidulus, Croton ericoides, Croton isabelli
(Vunda et al., 2012) and others have been studied.
Some of these plants are commonly used in natural medi-
cine. They show antiseptic or amoebicidal properties. Some
inhibit the development of amoebae, and others cause the
encystation of trophozoites. Some extracts are lethal only for
trophozoites but are not effective against cysts. A desirable
property of the plant extracts is a capacity for amoebostatic
and amoebicidal effects against trophozoites as well as cysts.
Until now, no plants that are effective in both cases have been
found. It seems that such a plant which fulfils both these
requirements is A. annua L.
A. annua is an annual plant which was described by Lin-
naeus. It grows wild in Asia (mainly Siberia, Japan, Korea and
China) and in southern Europe (Cullen 1975; Wąsowicz
2004). It was introduced to Poland, Denmark, Holland,
France, Italy, Lichtenstein and Austria, where it became do-
mesticated and bred (Tutin 1976; Wąsowicz 2004). As an
introduced plant, it also occurs in North America (Żukowski
and Piaszyk 1971; Cullen 1975).
A. annua is considered to be a medicinal plant, but in the
herbal literature, it is rarely mentioned (Jędrzejko et al. 1997;
Wąsowicz 2004). Its medicinal properties in malaria are
Fig. 1 Amoebae in agar culture on a Petri dish with A. annua L. extract
5 mg/ml (a). Control culture (b). Magnification ×100
Table 2 The survival time for
mice infected with
Acanthamoeba sp. following the
application of the plant extracts;
in each of group n = 6






Survival time of infected animals (days)
Methanol extract 7 ± 2 14± 2 20 ± 3 >28
Chloroform extract 7 ± 2 13± 3 19 ± 3 >28
Chinese water extract 10:1 7 ± 2 10± 4 15 ± 3 21 ± 5
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considered most important (De Donno et al. 2012; Ho et al.
2013). This plant is a species of particular significance in
tropical countries where the danger of malaria is the greatest
(Woerdenbag et al. 1994). In China, A. annua is officially
recognized as a medicinal plant and was listed in the Pharma-
copoeia (Woerdenbag et al. 1994). It is cultivated on a mass
scale in India, China and Vietnam.
The main medicinal substances of A. annua are
artemisinins, which are sesquiterpene lactones containing an
unusual peroxide bridge. The action of artemisinins involves,
among other things, the creation of free radicals which facili-
tate the fight against parasites with the result of splitting en-
doperoxide bonds in their structure. This peroxide is believed
to be responsible for the drug’s mechanism of action.
Moreover, artemisinin derivatives are effective against vi-
ruses (Efferth et al. 2008), protozoans (e.g. Toxoplasma gondii
(de Oliveira et al., 2009); Trypanosoma cruzi (Sülsen et al.,
2008); and Plasmodium falciparum (Sülsen et al., 2011), flat-
worms (e.g. Schistosoma japonicum, Schistosoma mansoni,
Fasciola hepatica, Clonorchis sinensis (Fathy, 2011), bacteria
and mushrooms (Lopes-Lutz et al. 2008). Artemisinin and its
derivatives show cytotoxic effects against cancer cells by
disrupting the cell cycle, promoting apoptosis and preventing
angiogenesis. The action of artemisinins also involves inhibi-
tion of Toll-like receptors (Ho et al. 2013).
Our study showed that water, alcohol and chloroform ex-
tracts of the herbA. annum L. can be used in acanthamoebiasis
for general and local treatment or in combined therapy with
antibiotics. Medicinal substances contained in this plant show
not only in vitro but also in vivo effects. In the case of animals
experimentally infected with amoebae of the genus
Acanthamoeba, it significantly prolongs their survival. Plant
extracts administered to experimentally infected animals have
considerably lengthened their survival time in comparison
with control animals that were not given any treatment. The
control animals that were infected usually died after 7 days.
The animals which received a plant extract monotherapy sur-
vived for a period three to four times longer or more. In the
case of animals that were not infected, the therapeutic doses of
drugs given did not display any toxic activity.
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